For the quarter ending 2025-09-30, PRCT made $83,327,000 in revenue. -$21,225,000 in net income. Net profit margin of -25.47%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 83,327,000 | 79,182,000 | 69,162,000 | 56,387,500 |
| Cost of sales | 29,321,000 | 27,436,000 | 25,001,000 | 22,034,500 |
| Gross profit | 54,006,000 | 51,746,000 | 44,161,000 | 34,353,000 |
| Research and development | 18,187,000 | 17,632,000 | 16,402,000 | 14,075,000 |
| Selling, general and administrative | 59,011,000 | 56,303,000 | 55,197,000 | 43,957,500 |
| Total operating expenses | 77,198,000 | 73,935,000 | 71,599,000 | 58,032,500 |
| Loss from operations | -23,192,000 | -22,189,000 | -27,438,000 | -23,679,500 |
| Interest expense | 919,000 | 895,000 | 877,000 | 1,007,000 |
| Interest and other income, net | 2,700,000 | 3,506,000 | 3,578,000 | 2,280,000 |
| Net loss | -21,411,000 | -19,578,000 | -24,737,000 | -22,406,500 |
| Foreign currency translation adjustment | 186,000 | -367,000 | 109,000 | - |
| Unrealized gain on cash equivalents | 0 | 0 | - | 80,500 |
| Comprehensive loss | -21,225,000 | -19,945,000 | -24,628,000 | -22,326,000 |
| Basic (in shares) | 55,727,000 | 55,445,000 | 54,917,000 | -25,754,000 |
| Diluted (in shares) | 55,727,000 | 55,445,000 | 54,917,000 | -25,754,000 |
| Net loss per share, basic (in dollars per share) | -0.38 | -0.35 | -0.45 | -0.425 |
| Net loss per share, diluted (in dollars per share) | -0.38 | -0.35 | -0.45 | -0.425 |
PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)